All In MedTech

FDA Clearance Tracker · P970034-S005

POSTERIOR CHAMBER INTRAOCULAR LENSES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 27, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 27, 2000

Approved

Time to decision

42 days

Received Feb 14, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970034-S005
Device name
POSTERIOR CHAMBER INTRAOCULAR LENSES
Applicant location
Ontario, CA
Received
Feb 14, 2000
Decided
Mar 27, 2000
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P970034

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

Approval for reducing the frequency of ethylene chlorohydrin residual testing from a quarterly basis to an annual basis.

Source documents

Other decisions for Aaren Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.